IDHC — Integrated Diagnostics Holdings Balance Sheet
0.000.00%
- $209.28m
- $219.28m
- EGP5.72bn
- 98
- 60
- 46
- 82
Annual balance sheet for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 877 | 2,350 | 816 | 861 | 1,752 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 364 | 447 | 510 | 685 | 1,011 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1,360 | 3,043 | 1,625 | 1,962 | 3,080 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,148 | 1,524 | 1,949 | 2,098 | 2,243 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 4,177 | 6,236 | 5,296 | 5,770 | 7,129 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,009 | 2,349 | 1,465 | 1,275 | 2,164 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,907 | 3,653 | 3,142 | 3,091 | 4,419 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2,270 | 2,583 | 2,154 | 2,679 | 2,710 |
Total Liabilities & Shareholders' Equity | 4,177 | 6,236 | 5,296 | 5,770 | 7,129 |
Total Common Shares Outstanding |